Differentiation of functional thyroid epithelia from pluripotent stem cells (PSCs) holds the potential for application in regenerative medicine. However, progress toward this goal is hampered by incomplete understanding of the signaling pathways needed for directed differentiation without forced overexpression of exogenous transgenes. Here we use mouse PSCs to identify key conserved roles for BMP and FGF signaling in regulating thyroid lineage specification from foregut endoderm in mouse and Xenopus. Thyroid progenitors derived from mouse PSCs can be matured into thyroid follicular organoids that provide functional secretion of thyroid hormones in vivo and rescue hypothyroid mice after transplantation. Moreover, by stimulating the same pathways, we were also able to derive human thyroid progenitors from normal and disease-specific iPSCs generated from patients with hypothyroidism resulting from NKX2-1 haploinsufficiency. Our studies have therefore uncovered the regulatory mechanisms that underlie early thyroid organogenesis and provide a significant step toward cell-based regenerative therapy for hypothyroidism.
In Brief
The molecular pathways governing thyroid differentiation are poorly understood. Kurmann et al. show that BMP4 and FGF2 activate key pathways that drive thyroid specification in vivo and in vitro, enabling differentiation of mouse and human pluripotent stem cells into thyroid follicular cells that produce thyroid hormones and rescue mouse hypothyroidism.
SUMMARY
Differentiation of functional thyroid epithelia from pluripotent stem cells (PSCs) holds the potential for application in regenerative medicine. However, progress toward this goal is hampered by incomplete understanding of the signaling pathways needed for directed differentiation without forced overexpression of exogenous transgenes. Here we use mouse PSCs to identify key conserved roles for BMP and FGF signaling in regulating thyroid lineage specification from foregut endoderm in mouse and Xenopus. Thyroid progenitors derived from mouse PSCs can be matured into thyroid follicular organoids that provide functional secretion of thyroid hormones in vivo and rescue hypothyroid mice after transplantation. Moreover, by stimulating the same pathways, we were also able to derive human thyroid progenitors from normal and disease-specific iPSCs generated from patients with hypothyroidism resulting from NKX2-1 haploinsufficiency. Our studies have therefore uncovered the regulatory mechanisms that underlie early thyroid organogenesis and provide a significant step toward cell-based regenerative therapy for hypothyroidism.
INTRODUCTION
Recent progress in the differentiation of pluripotent stem cells (PSCs) in vitro has allowed the derivation of desired cell lineages and in some instances their in vitro self-assembly into 3D structures, referred to as organoids (Lancaster and Knoblich, 2014; McCracken et al., 2014) . Transplantation and in vivo function of engineered cells has been less successful, typically because of poor engraftment. The derivation of PSC-derived endocrine tissues, such as pancreatic islets or thyroid follicles, provides particularly attractive opportunities to achieve in vivo function without orthotopic transplantation, because engraftment of these hormone-secreting tissues in any location with access to circulating blood would potentially achieve function and even clinical rescue of hormone deficiency. Indeed, the differentiation of PSCs into pancreatic islet-like cells has produced cells able to secrete insulin in vivo following transplantation (Pagliuca et al., 2014) . In marked contrast, thyroid epithelial cells displaying in vivo functional potential have been generated from PSCs only through forced overexpression of transcription factors (Antonica et al., 2012; Ma et al., 2013 Ma et al., , 2015 . The directed differentiation of PSCs in vitro into thyroid epithelial cells using growth factor-supplemented media previously has resulted only in immature cells that fail to express the full genetic program necessary for functional thyroid hormone biosynthesis (Arufe et al., 2006 (Arufe et al., , 2009 Jiang et al., 2010; Longmire et al., 2012; Ma et al., 2009) .
The primary hurdle preventing the successful differentiation of PSCs into mature thyroid cells has been a lack of knowledge of the pathways that regulate early thyroid embryonic development. ''Directed differentiation'' of PSCs involves sequential exposure of undifferentiated PSCs to a series of growth factorsupplemented media designed to recapitulate the sequence of developmental milestones that normally occurs during embryonic differentiation. This approach has been used to successfully produce a wide variety of non-thyroid lineages from PSCs (Murry and Keller, 2008) . The derivation of thyroid epithelial cells via directed differentiation remains a compelling goal given the known capacity of thyroid epithelia to self-organize and form follicular structures in vitro (Hilfer et al., 1968; Mallette and Anthony, 1966) . Moreover, recent work has demonstrated that thyroid cells generated from embryonic stem cells (ESCs) through forced overexpression of transcription factors also formed follicles in vitro or after transplantation in vivo (Antonica et al., 2012; Ma et al., 2015) .
Here we identify combinatorial bone morphogenetic protein (BMP) and fibroblast growth factor (FGF) signaling as necessary to induce thyroid fate in developing anterior foregut endoderm in multiple species, from amphibians to humans, and we use these pathways to induce thyroid fate in PSC-derived endodermal precursors via the technique of directed differentiation. Thyroid progenitors derived in this way can be sorted to purity using lineage-selective fluorochrome reporters for further culture expansion and subsequent maturation. During maturation in 3D culture, the resulting cells form thyroid follicular organoids with an organized monolayered epithelium consistent with thyroid follicles, express genes required for hormone biosynthesis, and can function in vivo following transplantation into hypothyroid mice. Thus we have developed an in vitro system able to reveal the basic developmental mechanisms and gene programs of thyroid cells at early stages of embryonic development, and we have produced an inexhaustible source of sortable cells with structural and functional thyroid follicular capacity.
RESULTS

Nkx2-1
+ Thyroid Cells Are Specified from ESC-Derived Endodermal Precursors upon Stimulation with Exogenous BMP4 and FGF2 We previously developed a directed differentiation protocol to produce ESC-derived definitive endodermal cells competent to form thyroid and lung epithelial lineages (Longmire et al., 2012) . We employed an ESC line (Nkx2-1 GFP ) carrying a knockin GFP reporter cDNA targeted to the locus encoding the homeodomain-containing transcription factor Nkx2-1, an essential regulator of thyroid and lung development. Within endoderm, Nkx2-1 is expressed only in lung or thyroid epithelia and is the first known protein induced upon endodermal specification to lung or thyroid fates. Nkx2-1 + cells induced from ESC-derived endoderm using our published (Longmire et al., 2012) six-factor cocktail (WFKBE+2; Figure 1A ) expressed thyroid epithelial-specific genes, such as thyroglobulin (Tg). However, these cells did not display full thyroid maturation, as the genes required for iodine metabolism and thyroid hormone biosynthesis were not robustly expressed (i.e., the sodium iodine symporter [Nis] and thyroid peroxidase [Tpo] ) ( Figure S1A and data not shown). Microarray analysis of the global mRNA expression profiles of these ESC-derived Nkx2-1 GFP+ endodermal progenitors (Figure 1A and Tables S1 and S2) revealed multiple active Figure 1C ), we sought to test the effects of Nkx2-1 gene dosage on thyroid differentiation in vitro. We compared the Nkx2-1 GFP ESC line with a non-haploinsufficient Nkx2-1 mCherry ESC line where the mCherry fluorophore is knocked in 3 0 to the coding sequence (Bilodeau et al., 2014) ( Figure 1C ). The two lines were differentiated in parallel, and Nkx2-1 GFP+ or
Nkx2-1 mCherry+ cells were sorted to purity on day 14 ( Figure 1D ), at which time the expression of Nkx2-1 mRNA was approximately 50% lower in the haploinsufficient Nkx2-1 GFP+ cells than in the non-haploinsufficient Nkx2-1 mCherry+ cells ( Figure 1E ).
The expression of both early (Pax8) and all mature thyroid markers analyzed (Tg, Tsh-r, Nis, and Tpo) in the outgrowth of sorted Nkx2-1 + cells was diminished in Nkx2-1 haploinsufficient cells ( Figure 1E ). This was confirmed when the Nkx2-1 GFP line was compared with its parental syngeneic, non-haploinsufficient clone ( Figure S1C ). In contrast, we did not detect any difference in the rates of lineage specification of Nkx2-1 + endodermal cells on day 14, comparing haploinsufficient with normal ESC lines. The percentages and cell numbers of Nkx2-1 + cells specified by day 14 were similar in the Nkx2-1 GFP line and its parental clone ( Figure S1B ), as well as in the Nkx2-1 mCherry line (data not shown). Thus, Nkx2-1 haploinsufficiency does not affect specification of Nkx2-1 + endodermal cells but does affect subsequent maturation of thyroid epithelial cells. This is supported by observations in mice and humans who have Nkx2-1 haploinsufficiency and hypothyroidism (Krude et al., 2002) .
The Expression of Pax8 Distinguishes a Subpopulation within Nkx2-1 + Endodermal Cells with Thyroid Potential
Having established a protocol able to produce putative thyroid follicular cells, next we sought to determine whether thyroid and lung lineage specification occurred in distinct endodermal Nkx2-1 + precursors, as is thought to occur in vivo. The Pax8 transcription factor is co-expressed with Nkx2-1 only in thyroid epithelial cells, beginning at mouse E8.5 and human E20 in the foregut endoderm within the region of the prospective thyroid primordium (Fagman and Nilsson, 2010; Trueba et al., 2005) . In contrast, Pax8 is not expressed at any developmental stage in lung epithelial cells. Hence, we developed a bifluorescent reporter system to track thyroid and non-thyroid fates in Nkx2-1 + cells by breeding mice with the GFP reporter targeted to the Nkx2-1 locus (Nkx2-1 GFP ; Longmire et al., 2012) ). The bars indicate average fold change in gene expression over ESCs ± SEM (n = 3 independent clones). both GFP and tdTomato reporters only in the thyroid epithelium, whereas GFP without tdTomato was expressed throughout the developing respiratory epithelium (Figures 2A and 2B ). As previously reported, GFP was also expressed within developing ectoderm in the ventral forebrain (Longmire et al., 2012) , and tdTomato without GFP was expressed in tissues known to express Pax8, including the kidney, hindbrain, midbrain, and inner ear ( Figure S2A and as published [Bouchard et al., 2004] Figures 2C, 2D , and S2B) and differentiated six lines in vitro using our Wnt3a, BMP4, and FGF2 Nkx2-1 induction protocol ( Figures 2E and 2F) . By day 14, all clones exhibited induction of the Nkx2-1 GFP reporter, with kinetics and efficiency similar to our previous report (Longmire et al., 2012) , and Pax8 tdTomato trace+ cells represented 4.9% (±4.7) of all Nkx2-1 + cells. On the basis of GFP and tdTomato expression, we sorted four distinguishable populations on day 14 ( Figure 2F ) and further differentiated each population until day 25 (Figures 2E and S2C) . Analysis of cells at the time of sorting (day 14) as well as until the full 25 days of differentiation of three clones revealed that only the day 14 sorted GFP + tdTomato + population gave rise to cells expressing the constellation of four transcription factors (Parlato et al., 2004 ) that together uniquely identifies thyroid epithelia (Nkx2-1, Pax8, Foxe1, and Hhex) and the differentiation marker Tg ( Figure 2E ). In contrast, this population was depleted of cells competent to express the differentiated lung marker genes Sftpc and Scgb1a1 (data not shown). In separate experiments using ESC lines that lack Pax8 reporters, we used fluorescence-activated cell sorting (FACS) analyses of intracellular protein to verify that Pax8 protein is expressed in approximately 5% of Nkx2-1 + ESC-derived cells (data not shown). We conclude that, as in the developing embryo, the thyroid lineage is specified in a distinct Nkx2-1 + endodermal population.
BMP and FGF Signaling Is Necessary and Sufficient for Thyroid Lineage Specification from Mouse and Xenopus Anterior Foregut Endoderm or ESC-Derived Definitive Endoderm
Having demonstrated that Pax8
were induced from PSC-derived endoderm by addition of Wnt3a, BMP4, and FGF2 (WB+2), we next sought to determine whether each pathway was necessary for thyroid lineage specification. In keeping with prior publications suggesting that Wnt is not required for thyroid specification from endoderm in vivo (Goss et al., 2009) , we found that Nkx2-1 GFP+ cells (Figure S1A) or Nkx2-1 mCherry+ cells ( Figure S3A ) derived with BMP4 and FGF2 induction media (days 6-14) in the absence of Wnt3a displayed undiminished subsequent expression of thyroid markers after outgrowth. Although either BMP4 or FGF2 alone induced small numbers of Nkx2-1 + cells with little thyroid competence ( Figures 3A and 3B ), combinatorial use of BMP4 and FGF2 induced the highest percentage of thyroid competent Nkx2-1 + progenitors, as evidenced by subsequent robust expression of all early and mature thyroid markers, including Pax8, Tg, Tsh-r, Tpo, and Nis (Figures 3B and S3A) . Consistent with these results, withdrawal of Wnt3a and/or addition of Wnt inhibitors Dkk1 or XAV-939 had no significant impact on the efficiency of lineage specification of Nkx2-1 GFP+ ;Pax8 tdTomato trace+ iPSC-derived cells by day 14, whereas there was a significant decrease in the percentage yield of GFP+/tdTomato+ cells when either BMP or FGF2 was removed from the Nkx2-1 induction media (data not shown).
To determine which downstream BMP and FGF signaling cascades are required for induction of thyroid fate, we supplemented the BMP4 + FGF2 media with specific inhibitors of either SMAD-dependent BMP signaling (Dorsomorphin), MEK1/2-dependent FGF or BMP signaling (PD98059; hereafter PD), PI3 kinase (PI3K)-dependent FGF signaling (LY294002; hereafter LY), or p38-MAPK-dependent BMP signaling (SB203580). We found reduced numbers and percentages of Nkx2-1 + cells in conditions supplemented with Dorsomorphin or LY ( Figure 3C ). Furthermore, when the rare Nkx2-1 + cells that were induced in the presence of these inhibitors were sorted to purity on day 14 and cultured further to allow completion of the protocol (without inhibitors), the progeny of these Nkx2-1 + cells showed reduced capacity to express mature thyroid markers, such as Tg and Tpo ( Figure 3D ). Taken together, our findings in the ESC/iPSC in vitro model system suggested that canonical Wnt signaling may be dispensable for thyroid lineage specification, while combinatorial SMAD-dependent BMP signaling together with FGF signaling is required. To test this hypothesis in primary cells of the developing embryo, we used both the murine and Xenopus models of embryonic foregut organogenesis (Figures 4 and S4) . First, in developing Xenopus embryos, we found evidence in support of active BMP and FGF signaling in the region of the thyroid primordium by immunostaining embryos for nuclear phospho-SMAD1/5/8, nuclear phospho-ERK1/2, and phospho-AKT ser473 proteins during early thyroid specification ( Figure S4A ). These phosphorylated signaling effectors were present in the foregut epithelium prior to and during the evagination of Nkx2-1 + cells of the developing thyroid anlage as well as in the surrounding mesenchyme ( Figure S4A ; stages NF20 and NF33). Next, to assess whether FGF and BMP signaling is required for thyroid specification in vivo, we incubated developing mouse as well as Xenopus embryos in inhibitors of BMP or FGF signaling (Figures 4 and S4 ). Developing mouse foreguts were isolated by dissection at 6-8 somite stage (ss) ($E8.0) prior to detectable Nkx2-1 expression in the thyroid field and incubated for 2 or 3 days with the BMP inhibitor DMH-1. DMH-1 caused a marked reduction in phosphorylation of SMAD1/5 ( Figure 4A , right, western blot) and blocked induction of both Nkx2-1 and Pax8 in the region of the mouse endodermal thyroid primordium ( Figure 4A , left). Similarly, we incubated developing Xenopus embryos in inhibitors of BMP signaling (DMH-1 or an injected dominantnegative BMPR) or FGF signaling (SU5402, PD161570, or an injected dominant-negative FGFR), starting just after gastrulation (stage NF13) until stage NF20 (6-7 ss). The inhibitors were then removed and embryos allowed to develop until stage NF34 (36 ss), a time by which thyroid and lung lineages are normally specified (Shifley et al., 2012) . In situ hybridization for markers of pharyngeal endoderm and thyroid lineage specification foxe1, nkx2-1, pax2, and hhex revealed that inhibition of either BMP or FGF signaling abrogated induction of all four thyroid markers in the vast majority of Xenopus embryos (Figures 4B and S4B) . Furthermore, inhibition of PI3K-AKT with LY also prevented thyroid specification ( Figure S4B ). Immunostaining of pSmad1/5/8, pERK, and pAKT confirmed the efficacy of the inhibitors ( Figure S4C ). In contrast, when Xenopus embryos were incubated from stage NF13 through NF35 in inhibitors of canonical Wnt signaling (XAV939), RA signaling (BMS493), or VEGF signaling (KRN633), we observed normal nkx2-1 induction in the thyroid primordium ( Figure S4B ), indicating that Wnt, RA, and VEGF signaling at these developmental stages is dispensable for thyroid specification.
To assess the stage dependence of these signaling requirements, we varied the timing of BMP and FGF loss of function during foregut endoderm development. We observed that early inhibition of BMP or FGF signaling beginning at stage NF13 (analogous to mouse E7.5) blocked induction of nkx2-1 ( Figure S4B ), whereas inhibition beginning later (at stage NF20; Figure S4D ) did not, suggesting that the requirement for BMP and FGF signaling in thyroid lineage specification is restricted to a narrow developmental window between stages NF13-20.
Because our mouse ESC model had predicted that FGF2 and BMP4 were sufficient to induce thyroid lineage specification, we next asked whether exogenous FGF2 and BMP4 were sufficient See Figure S3 .
to induce thyroid development in Xenopus foregut endoderm ( Figure 4C ). Foregut explants were micro-dissected at stage NF15, prior to thyroid specification, and the mesoderm was removed. The foregut endoderm explants were then cultured until stage NF35 either without growth factors or with a combination of FGF2 and BMP4. In situ hybridization revealed that only explants incubated with FGF2 and BMP4 expressed nkx2-1, pax2, and hhex ( Figure 4C ). We did not detect expression of sftpc in explants from sibling embryos (data not shown), suggesting that the nkx2-1 expression was thyroid and not respiratory epithelium. Taken together, these results from Xenopus and mouse embryo models extended our observations made in differentiating mouse ESCs and iPSCs, confirming that FGF signaling and BMP signaling are evolutionarily conserved pathways required for the specification of thyroid fate from developing endoderm both in vitro and in vivo ( Figure 4D) . 
TSH and 3D Culture Promotes ESCDerived Thyroid Follicular Maturation and Organoid Formation
Having interrogated the signals required for the induction of thyroid fate, next we focused on augmenting the maturation state of the thyroid epithelial progenitors generated from PSCs, using the Nkx2-1 mCherry ESCs. In contrast to lineage specification and early development, the expression of thyroid genes necessary for iodine metabolism, Nis and Tpo, is associated with later gland maturation ( Figure 5A ) and has been shown in vivo to require TSH receptor activation (Postiglione et al., 2002 ). Hence we tested the effect of TSH at various developmental stages of our in vitro protocol, either on induction of Nkx2-1 + progenitors (days 9-12) or during outgrowth of sorted Nkx2-1 + cells (days 14-22). We found that the addition of TSH prior to lineage specification (days 9-12) had no detectable effect on the efficiency of thyroid lineage specification or the competence of thyroid cells to subsequently differentiate (data not shown). In contrast, addition of TSH after lineage specification (days 14-22) resulted in increased Nis, Tsh-r, and Tpo expression ( Figure S5A ) but no significant change in the expression of lineage markers Nkx2-1 and Pax8 (data not shown). An additional 3 days of culture maturation in the presence of TSH was accompanied by further augmentation of Nis and Tsh-r expression ( Figure S5A ). We previously published augmented thyroid gene expression in ESC-derived Nkx2-1 + cells when using a thyroid medium containing IGF-1, insulin, transferrin, and selenium (Longmire et al., 2012) . Therefore, we included these additives, together with TSH, in our prior base medium of FGF2 + FGF10. This ''thyroid outgrowth medium'' was used for replating the sorted Nkx2-1 + cells on day 12 ( Figure S5B ). For the final maturation stages after expansion of sorted cells in ''thyroid outgrowth medium,'' we sought to further optimize expression of Nis and Tpo. Because we had observed induction of these markers in response to either DCI+K ( Figure 1E ) or in response to 1-100 mU/ml of TSH (data not shown), we tested the effect of combinations of each of these factors ( Figure S5C ; days 22-26). We found that withdrawal of either cyclic AMP (cAMP) or dexamethasone from the DCI+K cocktail adversely affected maturation ( Figure S5C) ; however, substitution of TSH for cAMP in the DCI+K medium retained maturation and resulted in the most robust expression of Nis ( Figure S5C ). Thus, the combination of dexamethasone and TSH was included in the final 4 days of maturation (days 26-30), resulting in the thyroid directed differentiation protocol summarized in Figure S5B and achieving the derivation from ESCs of a population of cells expressing thyroid marker transcripts at levels equal to (Nkx2-1, Hhex, Foxe1, Tpo) or within 10-fold of (Pax8, Tg, Tshr, Nis) post-natal murine thyroid control tissue ( Figure 5B ). To facilitate thyroid follicular structural formation during outgrowth of ESC-derived Nkx2-1 + cells, based on prior reports of Matrigel as a favorable thyroid culture substrate (Martin et al., 1993) , we tested the effect of 3D culture in Matrigel (days 12-30; Figures 5C and 5D ). Compared with 2D culture, we found that culture of purified Nkx2-1 mCherry+ cells in 3D Matrigel conditions resulted in higher expression of thyroid genes by qPCR (Nkx2-1, Pax8, Tg, Tsh-r, Tpo, and Nis; Figure 5C ), increased epithelial gene expression (increased E-Cadherin and EpCam expression and reduced mesenchymal markers Snail1, Twist, and Col1a1; Figure 5D ), and triggered the formation of follicular-like clusters of cells ( Figure 5E and 5G). These organoids could be further passaged and maintained in these culture conditions with stable or increased expression of Nkx2-1, Pax8, Hhex, Foxe1, Tg, Nis, Tshr, and Tpo until at least day 52 ( Figure S5D ). In addition, after incubation in iodinated media for 48 hr, the organoids displayed the functional capacity to organify iodine and produce small amounts of T4 hormone bound to TG in vitro at different time points during the differentiation protocol, beginning on day 30 ( Figure S5E ).
In Vivo Function of Purified ESC-Derived Thyroid Follicular Organoids following Transplantation into Hypothyroid Mouse Recipients
The defining functional characteristic of thyroid follicular epithelial cells is their capacity to synthesize and secrete thyroid hormones in vivo. Hence, we sought to test whether ESC-derived Nkx2-1 mCherry+ thyroid progenitors sorted on day 12 of differentiation and further matured into organoids until day 30 could function in vivo after transplantation and moreover whether these cells could rescue hypothyroid mice. Syngeneic mouse recipients underwent radioiodine ablation of their native thyroid tissue after 8 days of a low-iodine diet in order to induce severe hypothyroidism, evident as significantly reduced circulating plasma T4 and T3 levels and elevated circulating TSH levels (Figures 6A and 6B) . Four weeks later, we prepared one positive control mouse group (n = 5) that had not undergone radioiodine ablation, one negative control group that received sham surgery (n = 4), and two experimental recipient groups that received either undifferentiated ESCs (day 0 ESCs, hereafter ''D0-ESCs''; n = 5) or differentiated ESCs that had been sorted on day 12 on the basis of Nkx2-1 mCherry+ expression and further differentiated until day 30 in our complete 3D protocol (hereafter ''D30-ESCs''; n = 10). Following ESC transplantation with 2.5-3 3 10 6 cells beneath the left kidney capsule of each mouse recipient, we followed all recipient groups for at least 8 weeks post-transplantation, monitoring circulating T4, T3, and TSH levels, and we used both MRI and single-photon emission computed tomography (SPECT)/computed tomography (CT) to screen for in vivo graft growth and function (Figures 6 and S6) . Starting 2-4 weeks post-transplantation, recipients of D30-ESCs displayed augmented circulating T4 and T3 levels that continued to increase over time until they approached normal levels by 8 weeks after transplantation ( Figures 6B, S6A , and S6C). Reconstitution of T4 levels was accompanied by amelioration of the elevated plasma TSH levels ( Figures 6B, 6C , and S6B), further emphasizing that physiologic rescue was occurring. In a repeat experiment, some recipients followed for longer periods were observed to display circulating T4 reconstitution at normal levels for at least 29 weeks after transplantation (data not shown). In contrast, we observed no reconstitution of circulating thyroid hormone levels in either sham transplanted controls or recipients of D0-ESCs, excluding the possibility that either residual undifferentiated cells or re-growth of native thyroid tissue was responsible for the return of circulating T4 or the dampening of the TSH response.
To further evaluate the function of the transplanted cells, we incorporated imaging with sodium pertechnetate (Tc 99M ) and SPECT/CT co-registered with MRI. Importantly, the uptake of Tc 99M into thyroid tissue is mediated by Nis, allowing its visualization to be a surrogate for iodine uptake (Zuckier et al., 2004) . In recipients of D30-ESCs, we observed Tc 99M uptake occurring in the region of the kidney capsule grafts ( Figures  6D, 6E , and S6E). We also observed low levels of Tc 99M uptake in the large masses that derived from kidney capsule transplantation of D0-ESCs ( Figure S6D ), but in no D0-ESC recipient was this signal accompanied by detectable return of circulating T4 levels. As expected, Tc 99M uptake was not detected in the anatomical region of the native thyroid tissue of any ablated recipient ( Figures 6E and S6E) , further suggesting that return of thyroid function in D30-ESC recipients was not due to re-growth of native thyroid tissue.
To confirm the presence of engrafted D30-ESCs in vivo, we evaluated the histology of the renal lesions that had been visualized by MRI and SPECT (Figures 6F-6I ). As expected, recipients of D0-ESCs developed large teratomas ( Figure S6D ) without evidence of organized follicles, and only rare, if any, cells expressed nuclear Nkx2-1 protein (data not shown). In contrast, no teratomas were observed in recipients of D30-ESCs; instead, these recipients displayed persistent grafted cells beneath their kidney capsules organized into many follicular-like structures per high power field that were morphologically consistent with thyroid epithelial follicles ( Figure 6F ). These structures consisted of mCherry + epithelial cells expressing nuclear Nkx2-1 and Pax8 proteins by immunostaining, surrounding central lumens filled with colloid-like material that contained Tg and T4 ( Figures  6F-6H) . A subset of the grafted cells expressed the proliferation marker PCNA ( Figure 6I ). We did not detect expression of proSftpc in any grafted cell suggesting that Nkx2-1 expression resulted from thyroid and not respiratory epithelium ( Figure S6F ).
To assess whether the engrafted D30-ESCs functioned in a regulated fashion, we exposed additional D30-ESC transplanted mice, negative sham controls, and positive normal controls (n = 5 per group) to a high dose of exogenous T3 expected to fully suppress endogenous TSH and hence T4 production. Indeed, in all groups, administration of T3 resulted in TSH suppression and abrogated T4 secretion (data not shown). To further interrogate TSH responsiveness ( Figure S6G ), we then injected each mouse with exogenous bovine TSH and 3 hr later observed an increase in circulating T4 in positive control mice as well as in recipients of D30-ESCs, but not in sham controls, consistent with the regulation of engrafted cells by TSH.
These results indicate that ESC-derived thyroid follicular epithelial cells prepared by directed differentiation in serumfree, feeder-free conditions exhibit in vivo functional potential, including the capacity to rescue hypothyroid mice that otherwise lack native functional thyroid tissue.
Derivation of Human Thyroid Progenitors from ESCs and Hypothyroid Patient-Specific iPSCs
Finally, we sought to adapt our protocol to direct the differentiation of human ESCs and iPSCs into thyroid progenitors. Having observed that thyroid specification was not affected by Nkx2-1 haploinsufficiency in mouse PSCs (Figures 1 and S1 ), we hypothesized that BMP4 and FGF2 might also generate human thyroid progenitors in normal as well as haploinsufficient lines. Hence we obtained dermal fibroblasts from three hypothyroid children previously diagnosed with the brain-lung-thyroid syndrome arising from three different respective NKX2-1 coding sequence mutations ( Figures S7A and S7B ) that were predicted to cause NKX2-1 haploinsufficiency (Hamvas et al., 2013) . Using the STEMCCA reprogramming system (Somers et al., 2010) , we generated iPSC lines from each child's fibroblasts (hereafter T1, T3, and T4; Figures 7A, 7B , and S7C-S7E). Next, we derived definitive endoderm from each iPSC line as well as from control human ESCs (RUES2) and control iPSCs (BU3 and iPS17; Figure 7C and Supplemental Experimental Procedures). We used dual inhibition of TGFb and BMP signaling, as originally described by Green et al. (2011) in order to mimic anterior foregut patterning of each ESCs/iPSCs-derived endodermal population and then tested the capacity of varying concentrations of BMP4 and FGF2 to specify putative thyroid cells. Using the control RUES2 line, we varied the doses of BMP4 and FGF2 to identify a dosing combination that resulted in induction of clusters of NKX2-1+/PAX8+ co-expressing cells (Figures 7D and S7F ). This same dose induced NKX2-1+/PAX8+ cell clusters from human iPSC lines BU3 and iPS17, as well as from all three patient-specific iPSC lines ( Figure 7E , left, and Figure S7G ). BMP4 or FGF2 alone induced rare, if any, NKX2-1+/PAX8+ coexpressing cells in the T1, T3, T4, and RUES2 lines (data not shown). Furthermore, in BU3, iPS17, and T3 iPSC-derived endodermal cells subjected in parallel to published lung inducing medium (Huang et al., 2014) that contains BMP4 (with Chir, FGF10, FGF7, and RA [CFKBRA]) but lacks FGF2, we observed only induction of NKX2-1+ cells without co-expression of PAX8, suggesting that these cells were respiratory rather than thyroid ( Figure 7E, right) . As in our mouse ESC/iPSC experiments, NKX2-1+/PAX8+, putative thyroid progenitors induced after (legend continued on next page) 10 days of exposure to BMP4 and FGF2 expressed low to undetectable levels of TPO and TSH-R transcripts (data not shown). However, after further culture in the same thyroid differentiation and maturation conditions used for mouse ESCs, these thyroid differentiation markers were upregulated, and NKX2-1, PAX8, and TG expression was maintained for at least 42 days in culture ( Figure 7F ). As expected, without the use of a human NKX2-1 reporter for purification of human thyroid cells from these heterogeneous endodermal cultures, these thyroid markers were detected at significantly lower levels than adult human thyroid control tissue biopsies (data not shown). Taken together, these findings support the capacity of combinatorial BMP and FGF signaling to induce thyroid lineage specification from developing endoderm across species, from Xenopus to mice to humans, and enable the generation of patient-specific thyroid progenitors from individuals with genetic or congenital hypothyroidism.
DISCUSSION
Two applications of in vitro model systems, deriving from ESCs and iPSCs, are frequently touted: (1) the engineering of cellbased therapies able to durably ameliorate disease or regenerate tissue after a single transplantation treatment and (2) the production of an inexhaustible supply of purified cells of defined lineage at identifiable developmental stages for basic mechanistic studies. Here we demonstrate the application of ESCs and iPSCs toward both goals. We have used these cells to produce functional, transplantable thyroid follicular organoids able to produce circulating thyroid hormone in vivo at levels that rescue hypothyroid mice, and we have produced thyroid precursor cells at an early developmental stage, revealing that combinatorial BMP signaling and FGF signaling together are required for thyroid lineage specification from multi-potent definitive endoderm.
Although ESC/iPSC model systems frequently have been used to confirm or validate developmental signaling pathways identified in vivo or in explants, we used ESCs and iPSCs to discern a novel role for combinatorial BMP and FGF signaling in thyroid lineage specification, and argue against a role for any individual signaling pathway in isolation. Our findings agree with previous work suggesting a role for FGF signaling in early thyroid development. Our finding of nuclear pERK1/2 protein staining in endodermal Nkx2-1 + thyroid progenitors in Xenopus embryos is consistent with prior demonstrations of active FGF signaling in the developing Xenopus ventral foregut endoderm (Shifley et al., 2012) . Moreover, a role for FGF signaling in inducing thyroid cell fate has been previously demonstrated in mouse endodermal explant studies, in which the addition of exogenous FGF2 prior to thyroid specification induced Nkx2-1 and Tg (Serls et al., 2005) . In zebrafish models inhibition of FGF prior to specification leads to absence of a thyroid primordium (Wendl et al., 2007) , and mouse genetic models establish that FGF signaling is required for normal early thyroid development, with the adjacent cardiac mesoderm likely being the source of this signal (Celli et al., 1998; Fagman et al., 2007; Fagman and Nilsson, 2010; Kameda et al., 2009; Lania et al., 2009; Vitelli et al., 2002) . In contrast, only two prior studies, featuring Chordin mutant and Twisted mutant mice with perturbed BMP signaling, have reported thyroid hypoplasia, raising the possibility of a role for BMP signaling in thyroid development (Bachiller et al., 2003; Petryk et al., 2004) . These prior reports could not discern whether the thyroid defects were primary effects due to inhibition of lineage specification, reduced proliferation, or secondary effects due to perturbed cardiac field development. We used our PSC model system, confirmatory Xenopus embryos, and mouse developing foregut endoderm explant models to interrogate the period of thyroid lineage specification from endoderm. We observed that the BMP signal transducers phospho-SMAD1/5/8 are present in the nuclei of endodermal thyroid progenitors at the time of lineage specification, and SMAD-dependent BMP signaling is necessary for induction of the Nkx2-1 + thyroid program. The precise mechanisms by which BMP signaling induces thyroid fate warrants further study to determine whether these are similar to those that induce endodermal Nkx2-1 + lung progenitors.
Identification of the sequence of developmental signals that promote thyroid development from endoderm allowed us to perform the generation of functional thyroid follicular-like epithelial cells by the technique of ''directed differentiation'' of PSCs. In accordance with prior observations from mouse genetic models (Postiglione et al., 2002) , we observed TSH signaling to be dispensable for early thyroid specification; however, TSH promoted the maturation of the genetic program necessary for hormone synthesis. As suggested by observations made in patients with hypothyroidism due to NKX2-1 haploinsufficiency (Krude et al., 2002) , we also found thyroid differentiation subsequent to lineage specification to be profoundly sensitive to Nkx2-1 haploinsufficiency in our in vitro mouse model system. Furthermore, we were able to apply our protocol to successfully generate NKX2-1+/PAX8+ human thyroid progenitors in iPSCs generated from patients with brain-lung-thyroid disease presenting with hypothyroidism. However, these double positive clusters were rare events, possibly because of the NKX2-1 haploinsufficiency that causes the syndrome.
Because the defining feature of thyroid follicular epithelial cells is functional hormone biosynthesis, our transplantation studies provided an important functional assessment of the thyroid organoids we generated by directed differentiation. After transplantation beneath the kidney capsules of hypothyroid mouse recipients, we found evidence for durable, functional engraftment of the putative organoids, which after 8 weeks in vivo (1) retained recognizable structure, (2) continued to express the molecular phenotype of thyroid follicular epithelia, (3) produced circulating T4 and T3, and (4) were regulated by TSH. To prove that these grafted organoids derived from Nkx2-1 + endodermal precursors, an important aspect of our work involved the sorting (E) Immunostaining for NKX2-1 and PAX8 on day 17 of differentiation in multiple human iPSC lines in either thyroid or lung specification medium. Nuclei are counterstained with DAPI. The scale bars represent 50 mm.
(F) mRNA expression of thyroid marker genes. The bars indicate average fold change in expression over undifferentiated iPS17 mean ± SD (n = 3 biological replicates). *p % 0.05 and **p % 0.01 (Student's t test). See also Figure S7 .
to purity of only Nkx2-1 mCherry+ endodermal cells prior to transplantation. This sorting algorithm should also help minimize the chance of teratomas developing in vivo from any residual undifferentiated cells. Indeed, no teratomas were observed arising from the sorted, transplanted cells in any recipient in our studies.
In summary, we present a novel in vitro model system based on the directed differentiation of PSCs into thyroid progenitors and mature follicular epithelial organoids for basic developmental studies and in vivo functional thyroid tissue regeneration. This system recapitulates the developmental milestones of early thyroid development, revealing previously unknown mechanisms of thyroid organogenesis. Successful functional transplantation of the resulting cells also suggests the feasibility of a potential future cell-based therapy for hypothyroidism.
EXPERIMENTAL PROCEDURES
Experimental methods are further detailed in the Supplemental Information and in downloadable protocols posted online at http://www.bumc.bu.edu/ stemcells.
Animal Maintenance
All studies involving mice carrying GFP and tdTomato reporters were approved by the Institutional Animal Care and Use Committee of Boston University School of Medicine. All murine transplantation experiments were approved by the Beth Israel Deaconess Medical Center Institutional Animal Care and Use Committee.
Mouse ESC and iPSC Lines
Derivation of the Nkx2-1 GFP and Nkx2-1 mCherry knockin reporter ESC lines by homologous recombination was previously published and is further detailed in the Supplement Information (Bilodeau et al., 2014; Longmire et al., 2012) . The Nkx2-1 GFP ;Pax8 tdTomato trace iPSC reporter line was generated by transduction of MEFs with the dox-inducible Tet-STEMCCA reprogramming lentiviral vector. All ESCs and iPSCs were maintained on fibroblast feeder layers using serum-containing media and LIF (ESGRO Chemicon).
Mouse ESC/iPSC Directed Differentiation
Cell differentiation was performed in complete serum-free differentiation medium (cSFDM; see Supplemental Experimental Procedures) supplemented with the indicated factors. Briefly, definitive endoderm was induced in embryoid body suspension cultures with 50 ng/ml Activin A (R&D), as previously published (Longmire et al., 2012) . Next, 100 ng/ml mNoggin (R&D) and 10 mM SB431542 (Sigma) was applied for 24 hr to generate anterior foregut endoderm. Expression of Nkx2-1 was induced with specification medium containing 100 ng/ml mWnt3a, 10 ng/ml mKGF, 10 ng/ml hFGF10, 10 ng/ml mBMP4, 20 ng/ml hEGF, and 250 ng/ml mFGF2 (all from R&D). After Nkx2-1 induction, cells were sorted on days 12-14 by flow cytometry on the basis of expression of GFP, mCherry, or tdTomato reporters and then replated for either 2D or 3D culture outgrowth as indicated. For 2D outgrowth, plated cells were grown in gelatin-coated dishes for 8 more days in cSFDM with 250 ng/ml mFGF2, 100 ng/ml hFGF10, and 100 ng/ml heparin sodium salt. On day 22, the medium was switched to DCI+K maturation medium (see Supplemental Experimental Procedures). For 3D outgrowth, cells were plated in pure growth factor reduced Matrigel drops (Corning) in cSFDM supplemented with 250 ng/ml mFGF2, 100 ng/ml hFGF10, 50 ng/ml mIGF-1, 25 ng/ml hEGF (all from R&D), 100 ng/ml heparin sodium salt, 10 mg/ml insulin (Sigma), and 1 mU/ml bTSH (Los Angeles Biomedical Research Institute). On day 26, medium was switched to thyroid maturation medium (Ham's F12 supplemented with 15 mM HEPES, 0.8 mM CaCl 2 , 100 ng/ml heparin sodium salt, 0.25% BSA, 50 ng/ml mIGF-1, 5 mg/ml insulin, 5 mg/ml ITS, 25 ng/ml hEGF, 50 nM dexamethasone, and 100 mU/ml bTSH) until the harvest day indicated.
Human iPSC Derivation
Procurement of all human specimens was approved by the Institutional Review Boards of the University of Colorado and Boston University. Three hypothyroid individuals diagnosed with brain-lung-thyroid syndrome arising from mutations in NKX2-1 were identified, and their dermal fibroblasts were reprogrammed with the STEMCCA reprogramming system to generate iPSC lines T1, T3, and T4 (Somers et al., 2010 
